EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, CA and STOCKHOLM – Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that it has acquired the IP and related assay assets of EEL Transcriptomics AB, a privately-held company focused on high-plex spatial transcriptomics […]
MONTREAL & BOSTON — Nomic Bio (“Nomic”), the protein profiling company, today announced the closing of an oversubscribed US$17 million Series A funding round, bringing the company’s total funding to date to over US$21 million. The round was led by Lux Capital and joined by SR One and Casdin Capital, with participation from prior institutional investors. […]
CONTRIBUTING TO STEM EDUCATION ENCOURAGES THE NEXT GENERATION OF SCIENTISTS IRVINE, Calif. — Zymo Research announced today that it is partnering with YARD Sciences to give high school students up-close and personal experiences with scientific laboratories. Zymo Research has donated $10,000 to YARD Sciences to help purchase vitally needed laboratory equipment to support YARD Sciences’ mission […]
Ready-to-Use Reagents to Advance Spatial Biology Research Fluorescent image of human lung cancer FFPE sample with 13 protein biomarkers illuminated using the Spatial Immune Profiling Kit for ChipCytometry. ST. LOUIS, Missouri – Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometryTM, a quantitative, high dynamic […]
Sengenics, THE Functional Proteomics Company, is pleased to announce the signing of new sales and marketing agreements with major distributors in East Asia to make our suite of products and services more widely accessible to customers in the region. Our new partners will market and provide full support for Sengenics’ proprietary technology to pharmaceutical, biotech […]
Image segmentation enables the software to reliably distinguish cells, nuclei and other objects WALTHAM, Mass. — The scanR high-content screening (HCS) station provides fully automated image acquisition and data analysis. Version 3.3 improves the deep-learning technology’s capabilities to reliably separate objects in biological samples using instance segmentation, the ability to detect and delineate distinct objects […]
MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The study will leverage PacBio’s HiFi long-read sequencing technology for whole genome sequencing (WGS) to look […]
– Represents First Industry Standard Control for Cancer Testing – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, today announced the launch of the Twist cfDNA Pan-cancer Reference Standards, a high-quality standardized control for use in the development and […]
The 2-year deal with Gene Therapies, Biosimilars, and Monoclonal Antibodies Pharmaceutical Equipment Technology will see nearly 100 of CYTENA’s latest portfolio of cell isolators including the UP.SIGHT be distributed to the massive Chinese life science market Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to distribute […]
GHENT, BELGIUM — Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell therapy – an anti-cancer treatment that has become an integral part of modern medicine. Trince has raised EUR 4 million from Novalis […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
